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The wealth of available genetic information is allowing
the reconstruction of human demographic and adaptive
history. Demography and purifying selection affect the
purge of rare, deleterious mutations from the human
population, whereas positive and balancing selection
can increase the frequency of advantageous variants,
improving survival and reproduction in specific
environmental conditions. In this review, I discuss
how theoretical and empirical population genetics
studies, using both modern and ancient DNA data,
are a powerful tool for obtaining new insight into
the genetic basis of severe disorders and complex
disease phenotypes, rare and common, focusing
particularly on infectious disease risk.climatic, nutritional, and pathogenic environments theyIntroduction
Intense research efforts have focused on identifying rare
and common variants that increase disease risk in humans,
for both rare and common diseases. Several, non-mutually
exclusive models have been proposed to explain the func-
tional properties of such variants and their contributions to
pathological conditions, and this topic has been reviewed
elsewhere [1–10]. These studies implicated multiple vari-
ants in disease susceptibility, but the relative importance of
rare and common variants in phenotypic diversity, both be-
nign and disease-related, has yet to be explored in detail
[11]. We can use an evolutionary approach to tackle this
question, as population genetics models can predict the al-
lelic architecture of disease susceptibility [12, 13]. They are
able to do so because rare and common disease-risk alleles
are a subset of global human genetic diversity, and their
occurrence, frequency, and population distribution is gov-
erned by evolutionary forces, such as mutation, genetic driftCorrespondence: quintana@pasteur.fr
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and natural selection.
The plethora of genetic information generated in the
last ten years, thanks largely to the publication of se-
quencing datasets for both modern human populations
and ancient DNA samples [14–18], is making it possible
to reconstruct the genetic history of our species, and to
define the parameters characterizing human demographic
history: expansion out of Africa, the loss of genetic diversity
with increasing distance from Africa (i.e., the “serial founder
effect”), demographic expansions over different time scales,
and admixture with ancient hominins [16–21]. These stud-
ies are also revealing the extent to which selection has acted
on the human genome, providing insight into the way in
which selection removes deleterious variation and the po-
tential of human populations to adapt to the broad range of
have occupied [22–28]. It has thus become essential to
dissect the role of selection, in its diverse forms and in-
tensities, in shaping the patterns of population genetic
diversity (Fig. 1a), not only to improve our understanding
of human evolutionary history, but also to obtain insight
into phenotypic diversity and differences in the risk of de-
veloping rare and common diseases [12, 13, 24, 29–32].The removal of mutations deleterious to human
health
Studies of the occurrence, frequency, and population
distribution of deleterious mutations are of fundamental
importance if we are to understand the genetic architec-
ture of human disease. Theoretical and empirical popula-
tion genetics studies have shown that most new mutations
resulting in amino acid substitutions (non-synonymous)
are rapidly culled from the population through purifying
selection (Fig. 1a) [33, 34]. Indeed, the small number of
non-synonymous variants observed relative to the rate of
non-synonymous mutation indicates that most non-
synonymous mutations are lethal or highly deleterious,
strongly compromising the reproductive success of their
carriers [34–36]. Purifying selection—the most commonle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
Fig. 1 Modes in which selection or admixture can remove, maintain, or increase genetic diversity. a Schematic representation of the different
types of natural selection. Purifying selection removes deleterious alleles (in black) from the population, and genes evolving under strong purifying
selection are usually associated with rare, severe disorders. Conversely, mutations conferring a selective advantage (e.g., increased resistance to
complex infectious disease) can increase in frequency in the population, or be maintained, through different forms of positive and balancing selection.
Positive selection is represented here by the classic hard-sweep model where, following an environmental change, a newly arisen advantageous
mutation or a mutation at very low frequency (in red) will be immediately targeted by positive selection and will ultimately reach fixation.
Balancing selection is illustrated here by the case of heterozygote advantage (or overdominance), where the presence of heterozygotes (in
blue) is favored in the population. b Long-term balancing selection. Advantageous genetic diversity can be maintained over long periods of
time and survive speciation, resulting in “trans-species polymorphism” (represented by black and red arrows). In this example, a trans-species
polymorphism that is present in the modern European population (where it has survived the known bottleneck out of Africa) is shared with
other primates, such as chimpanzees and gorillas. c Modern humans can also acquire genetic diversity (whether advantageous or not) through admixture
with other hominins, such as Neanderthals or Denisovans (Box 2). The green and blue arrows represent the direction and estimated magnitude of
admixture between modern humans and Neanderthals and Denisovans, respectively (see [17])
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that are deleterious, such as those associated with severe
Mendelian disorders, or their maintenance at low popula-
tion frequencies (i.e., mutation–selection balance) [32, 37].
The efficacy of purifying selection for eliminating deleteri-
ous mutations from a population depends not only on the
selection coefficient(s), but also on population size (N),
which determines the magnitude of genetic drift. Unlike
highly deleterious mutations, variants subject to weaker
selection (i.e., weakly deleterious mutations) behave like
“nearly neutral mutations”; they may, therefore, reach rela-
tively high population frequencies [38–40]. In large out-
bred populations, with low levels of drift, deleterious
mutations will eventually be eliminated. By contrast, in
small populations, deleterious mutations behave very
much like neutral mutations and may be subject to strong
drift, resulting in moderate-to-high frequencies, or even
fixation [39].
Rare variants are widespread in the human genome
Recent deep-sequencing studies are showing a surpris-
ingly high proportion of rare and low-frequency variants
in different human populations [14, 15, 41–47]. The Ex-
ome Variant Server, for example, reports frequency in-
formation from 6515 exomes of individuals of African
American and European American ancestry [46]. The
most recent release of the 1000 Genomes Project, based
on full-genome information for 2504 individuals from 26
populations from around the world, revealed that there
was a large number of rare variants in the global dataset
(~64 million autosomal variants have a frequency <0.5 %,
and only ~8 million have a frequency >5 %), with each in-
dividual genome harboring between 40,000 and 200,000
rare variants [15]. A more recent report of high-quality ex-
ome data from 60,706 individuals of diverse geographic
ancestry, generated as part of the Exome Aggregation
Consortium (ExAC), has provided unprecedented reso-
lution for the analysis of low-frequency variants as well as
an invaluable resource for the clinical interpretation of
genetic variants observed in disease patients [47].
The contribution of rare variants to human disease is
a matter of considerable debate, together with the distri-
bution of these variants in the population, as they may
underlie early-onset disease and increase susceptibility to
common diseases [1, 44, 45, 48–50]. Most rare variants
are private to a population, whereas common variants
tend to be shared by different populations [51]. Rare vari-
ants, particularly those specific to a particular population,
tend to have stronger deleterious effects than common
variants [42, 52, 53]. Consequently, as shown by popula-
tion genetics studies, most variants with large functional
effects tend to be rare and private, and only a small
proportion of variants with large effects are common to
different populations. Genome-wide association studies(GWAS), which focus on common variants, have been
only moderately successful in explaining the genetic basis
of complex diseases [3]. Furthermore, theoretical studies
have shown that a large proportion of the so-called “miss-
ing heritability” is explained by rare variants, particularly
those that affect fitness as well as causing disease [54].
The increasing amount of sequence-based datasets
available, both in basic and medically oriented research,
is accelerating the investigation into the contribution of
rare variants to disease susceptibility. In this context, di-
verse variant annotation tools and predictive algorithms
have been developed to systematically evaluate the po-
tential functional impacts of genetic variants (e.g., Poly-
Phen, SIFT, and GERP) [55–57], helping to prioritize the
study of putative causal variants in further detail. These
methods, which use different statistics and types of in-
formation, generally assess the “deleteriousness” of each
genetic variant by considering different measures, such
as evolutionary conservation scores, changes in amino
acid sequence, or potential effect on protein function
and structure [58]. Novel methods are increasingly being
developed, providing improved power and resolution.
For example, CADD, which integrates both evolutionary
and functional importance, generates a single prediction
from multiple annotation sources, including other variant
effect predictors [59]. Likewise, MSC provides gene-level
and gene-specific phenotypic impact cutoff values to im-
prove the use of existing variant-level methods [60].
Quantification of the burden of deleterious, mostly
rare, variants across human populations and an under-
standing of the ways in which this burden has been
shaped by demographic history are now key issues in
medical research, because they could help to optimize
population sampling and, ultimately, to identify disease
risk variants.
Expansion out of Africa and the patterns of rare,
deleterious variants
The sizes of human populations have changed radically
over the last 100,000 years, due to range expansions,
bottlenecks, and rapid growth over different timescales
[18–21]. Several studies have evaluated the impact of
such demographic events on the distribution of deleteri-
ous variants and have shown that populations that have
experienced bottlenecks, such as non-Africans, have
higher proportions of deleterious variants of essential
genes than African populations. This pattern has been
interpreted as resulting from weaker purifying selection
due to the Out-of-Africa bottleneck [45, 52, 61]. Neverthe-
less, an absolute increase in the number of rare functional
variants has been observed in populations of African and
European descent, relative to neutral expectations, due to
the combined effects of an explosive expansion over
recent millennia and weak purifying selection [41–46].
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to have arisen during the last 5000 to 10,000 years, and
these variants are enriched in mutations with a (relatively)
large effect as there has not yet been sufficient time for se-
lection to eliminate them from the population [46]. Fur-
thermore, deleterious mutations in Europeans appear to
have occurred after those in Africans (~3000 vs. 6200 years
ago, respectively) [46], highlighting the effects of demo-
graphic history on the distribution of deleterious variants
within the population.
However, some studies have suggested that demographic
history may have a less straightforward impact on the
mean burden of deleterious variants [62–64]. Simons and
coworkers concluded that individual mutation load is
insensitive to recent population history [64], and Do
and coworkers suggested that selection is equally effective
across human populations [62]. Several factors underlie
these apparently conflicting conclusions, including dif-
ferences in the choice of statistics and the features of
genetic variation used to assess the burden of deleterious
variation, and differences in the choice of predictive al-
gorithms for defining deleteriousness, together with dif-
ferences in the interpretations of the results; these
factors have been reviewed in detail elsewhere [22, 65].
Nevertheless, all these studies converge to suggest that
demographic history affects deleterious and neutral vari-
ants differently (Fig. 2), and that mutation and drift have
stronger effects on the frequency of weakly deleteriousFig. 2 Demographic history affects the proportion of deleterious variants in
currently segregating in the population can vary depending on the past
demographic expansions alone, populations display higher levels of gene
deleterious variants (in brown) than under regimes in which populations
opposite patterns are observed. The schematic demographic models pre
modern human populations (e.g., Africans, Europeans, and French Canad
population size over timemutations in bottlenecked populations than in large,
expanding populations.
Founder effects and bottlenecks increase the burden of
deleterious variation
Besides the impact of long-term population demographics
(i.e., African vs. non-African populations) on the distribu-
tion of deleterious variants, a few studies have evaluated
the effects of more recent, or stronger, changes in popula-
tion demography. For example, it has been shown that
French Canadians have both lower levels of diversity
and a larger proportion of deleterious variants than the
present-day French population. These findings highlight
how a recent major change in population demographics
(i.e., a small founder population of ~8500 French settlers
subsequently growing by about 700-fold to attain its
present size) can profoundly affect the population’s genetic
landscape within as little as 400 years [66]. Likewise, the
Finnish population, which experienced a recent popula-
tion bottleneck estimated to have occurred ~4000 years
ago, has larger proportions of rare deleterious alleles,
including loss-of-function variants and complete gene
knockouts, than other populations in Europe or of
European descent [67].
Henn and coworkers investigated the consequences of
a serial founder effect model for the distribution of dele-
terious mutations using a set of African populations and
several groups located at different geographic distancesthe human population. The proportion of deleterious variants
demographic regime of each population. Under a regime of
tic diversity (in total absolute counts) and lower proportions of
have experienced bottlenecks or recent founder events, where the
sented here illustrate the broad demographic history of some
ians), but they do not attempt to capture their precise changes in
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considering different selection coefficients and dominance
parameters, they found that non-African individuals car-
ried larger proportions of deleterious alleles, mostly of
modest effect, than African individuals, and that the num-
ber of homozygous deleterious genotypes carried by indi-
viduals increased with distance from Africa [68]. These
results highlight the interaction between drift and purify-
ing selection by showing that deleterious alleles previously
maintained at low frequencies by purifying selection may
have surfed to higher frequencies in populations at the
edge of the wave expanding out of Africa, due to stronger
drift [53, 68, 69]. Together, these studies suggest that
demographic history has played a central role in shaping
differences in the genetic architecture of disease between
human populations through its effects on the frequency of
deleterious alleles [64, 70].
Favoring advantageous variants to increase
adaptation
Besides the interplay between drift and selection to re-
move deleterious mutations, other de novo or already
existing variants can be advantageous and can increase in
population frequency through various forms of positive
and balancing selection [23–28, 71, 72]. Humans occupy
diverse habitats and have gone through many different
cultural and technological transitions; human populations
have had to adapt to such shifts in habitat and mode of
subsistence [25]. Dissecting the legacy of past genetic
adaptation is thus key to identifying the regions of the
genome underlying the broad morphological and physio-
logical diversity observed across populations, and to in-
creasing our understanding of the genetic architecture of
adaptive phenotypes in health and disease.
Positive selection targets mendelian and complex traits
Positive selection can manifest in different guises: from
the classic, hard-sweep model, in which a new mutation
can confer an immediate fitness benefit (Fig. 1a), to al-
ternative models of genetic adaptation, such as selection
on standing variation or polygenic adaptation [73, 74],
with each type of selection leaving a specific molecular
signature in the targeted region (reviewed in [23, 26]).
Most studies have focused on signals of positive selec-
tion according to the hard-sweep model, providing
insight into the nature of adaptive phenotypes (see
[23, 24, 26, 29, 31, 72, 75–77] and references therein).
These phenotypes range from Mendelian traits (or al-
most so)—including the largely supported lactase per-
sistence trait in various populations [78–82] and traits
relating to infectious disease resistance (e.g.,G6PD, DARC,
FUT2) in particular (reviewed in [76])—to complex traits,
such as skin pigmentation [83–86], adaptation to climate
variables or high altitude [87–93], and the immuneresponse and host–pathogen interactions [24, 29, 31, 77,
94–107]. These examples reveal the potent selective pres-
sures that have been exerted by nutritional resources, cli-
matic conditions, and infectious agents since humans first
began to spread over the globe [29, 31, 72, 77, 96, 108].
Many selection signals were detected by candidate-
gene approaches, based on a priori choices of the genes
and functions to be investigated. However, a large
number of genome-wide scans for positive selection
have identified several hundred genomic regions dis-
playing selection signals, consistent with the likely
presence in these regions of beneficial, functional variants
[28, 37, 109–124]. For example, Grossman and coworkers
identified about 400 candidate regions subject to selection,
using whole-genome sequencing data from the 1000 Ge-
nomes Project [28]. These regions either contain genes in-
volved in skin pigmentation, metabolism and infectious
disease resistance, or overlap with elements involved in
regulatory functions, such as long intergenic noncoding
RNAs and expression quantitative trait loci (eQTL). The
presence of non-synonymous variants in less than 10 % of
the candidate-selected regions suggests that regulatory
variation has played a predominant role in recent human
adaptation and phenotypic variation [28], as previously
suggested [125–128].
The large number of studies searching for selection
signals contrasts with the much smaller number of stud-
ies trying to determine when selection effects occurred
[83, 129, 130]. Nevertheless, such studies could identify
specific time periods corresponding to abrupt changes in
environmental pressures. Studies aiming to date the lac-
tase persistence allele in Europe have suggested that this
allele was selected in farmers some 6000 to 11,000 years
ago [79, 81, 95, 129, 130], although estimates based on
ancient DNA point to a more recent time [131, 132] (see
below). A recent study, using an approximate Bayesian
computation framework, found that skin pigmentation
alleles were generally much older than alleles involved in
autoimmune disease risk, whose ages are consistent with
selection during the spread of agriculture [129]. A report
suggesting that many selective events targeting innate
immunity genes have occurred in the last 6000 to
13,000 years [95] provides additional support for the no-
tion that the adoption of agriculture and animal domes-
tication modified human exposure to pathogens, leading
to genetic adaptations of immune response functions.
Selection studies have thus increased our knowledge
of the nature of several adaptive phenotypes at different
timescales (Box 1), but the relative importance of selection
according to the classic sweep model remains unclear.
Several studies have reported the prevalence of classic
sweeps for human adaptation to be non-negligible [28,
109–113, 115–118, 122], whereas others have suggested
that such sweeps are rare and that the corresponding
Box 1. To what extent has positive selection continued
in recent times?
Many human traits related to healthy or disease conditions appear
to have conferred selective advantages in the past [23–28, 71, 109],
but the extent to which selection has persisted in very recent times
remains largely unknown. This is because current methods of
detecting positive selection are designed to measure selection over
long evolutionary timescales [24, 26]. A recent study has developed
a new method, the Singleton Density Score (SDS), to infer
recent changes in allele frequencies using modern whole-
genome sequence data, and to measure selection during the
past 2000 years [190]. Using simulations, they first showed that
SDS has equal power to detect hard and soft sweeps within
recent evolutionary timescales. By applying SDS to more than
3000 full genomes of British ancestry, they identified several
alleles and traits that have provided, or continue to provide, a
strong selective advantage over the last 2000 years. Among
the strongest hits, they found the lactase persistence allele,
indicating that the known selective advantage provided by this
allele [78, 81] has persisted in very recent times. They also
detected strong signals of recent positive selection in the HLA
region (associated with multiple traits and diseases), in genes
involved in skin pigmentation (likely favoring blond hair and
blue eyes through sexual selection), and some cases of recent
polygenic adaptation favoring increased height, increased infant
head circumference and birth weight, later sexual maturation in
women, and decreased levels of insulin and glycated hemoglobin
[190]. This study provides a new method to test the extent to
which selection on complex traits, either following the hard-sweep
model or reflecting polygenic adaptation, has shaped phenotypic
diversity in other human populations within historical times.
Quintana-Murci Genome Biology  (2016) 17:225 Page 6 of 14signals probably result from background selection
[74, 93, 123, 124]. There is also increasing evidence to
suggest that other, largely undetected forms of genetic
adaptation, such as selection on standing variation, poly-
genic adaptation, and adaptive introgression [73, 74],
may have occurred more frequently in the course of
human evolution than previously thought (see for ex-
ample [108, 130, 133–135]).
Maintaining diversity through balancing selection
Balancing selection can preserve functional diversity,
through heterozygote advantage (or overdominance;
Fig. 1a), frequency-dependent selection, advantageous
diversity fluctuating over time and space in specific
populations or species, and pleiotropy [27, 136, 137].
Unlike other forms of selection, balancing selection can
maintain functional diversity over periods of millions ofyears because selection conditions remain constant over
time and are strong enough to avoid the loss of selected
polymorphisms due to drift. In some cases, polymor-
phisms subject to balancing selection can persist during
speciation events, resulting in trans-species polymorphism
(long-term balancing selection; Fig. 1b). In other cases,
balancing selection may occur only in particular species or
populations, owing to specific environmental pressures
(see [27, 136] and references therein). Until a few years
ago, evidence for the action of balancing selection was re-
stricted to a few loci, including the sickle cell hemoglobin
polymorphism (HbS), which protects against malaria in
the heterozygous state [138], and several genes of the
major histocompatibility complex (MHC, or HLA in
humans), which presents intracellular peptides to cells
involved in immune surveillance and triggers immune
responses against diverse pathogens [139–141].
Recent studies, bolstered by the whole-genome se-
quence data published for humans and other species, have
suggested that balancing selection is more prevalent than
previously thought (see [27] for a review). Several studies
searching for the occurrence of trans-species polymorph-
ism have shown that advantageous variants in the human
population may have been inherited from distant ancestral
species [142–145]. For example, functional diversity in
ABO blood group has been maintained across primates
for millions of years, probably due to host–pathogen co-
evolution [142]. Likewise, a scan of long-term balancing
selection in the genomes of humans and chimpanzees has
detected 125 regions containing trans-species polymor-
phisms, principally in genes involved in immune function,
such as IGFBP7 and membrane glycoprotein genes; these
findings suggest that there has long been functional
variation in response to pressures exerted by pathogens
in these species [144]. Other studies have searched for
balancing selection within humans through the use of
genome-wide approaches or by focusing on particular
gene families. Selection signatures have been detected
in multiple regions, including the KIR gene regions
(KIR genes are known to co-evolve with their HLA li-
gands [146]), and regions encoding various molecules
involved in cell migration, host defense, or innate im-
munity [146–155]. These studies indicate that, despite
its low occurrence, balancing selection has maintained
functional diversity at genes involved in functions relating
to the immune response, as observed for other types of
selection [24, 29, 31, 77, 103].
Tracking selection signatures from ancient DNA data
Population genetics methods can be used to estimate the
approximate age and selection coefficient of adaptive
mutations from data from modern human populations,
with various degrees of confidence. However, the use of
ancient human samples from different time periods is
Box 2. Archaic admixture and disease risk in modern
humans
One source of adaptive genetic variation is variants from donor
populations that have undergone introgression into recipient
populations (or species) through interbreeding or admixture, a
phenomenon known as adaptive introgression. During the
dispersals of modern humans through Eurasia, they encountered
other human forms, such as Neanderthals and Denisovans
[16, 17, 156–158]. Analyses of whole-genome sequences from
these hominins [191, 192] have shown that admixture between
modern and archaic humans occurred, with modern Eurasian
genomes comprising 1–6 % of Neanderthal or Denisovan ancestry
(Fig. 1c) [191, 193–197]. However, these estimations are averaged
across the genome, and it has been shown that the degree of
archaic ancestry in the modern human genome varies considerably
[194, 198, 199]. A systematic search for regions of Neanderthal
ancestry in the genomes of modern humans has shown that,
globally, purifying selection has acted against Neanderthal
introgression, particularly in protein-coding regions [194]. However,
some regions of the genome can present a high degree of
Neanderthal ancestry, which can be as high as 62 % in Asian
and 64 % in European populations [194].
Some of the regions presenting the highest degree of Neanderthal
ancestry have been found to overlap alleles that have been
associated with phenotypes of medical relevance, such as lupus,
biliary cirrhosis, Crohn’s disease, optic-disk size, smoking behavior,
IL-18 levels, type 2 diabetes, and hypercoagulation [194, 200]. In
some cases, the introgression of archaic segments into the genomes
of modern humans appears to have been adaptive [194, 198]. Cases
of adaptive introgression from Neanderthals or Denisovans have
been reported for several genes (see [16] for a complete list), such
as EPAS1, involved in human adaptation to life at high altitude [201],
BNC2, involved in skin pigmentation [194, 198], and an increasing
number of genes involved in immunity to infection, including
several HLA genes [202], STAT2 [203], the OAS gene cluster
[204, 205], and the TLR6-TLR1-TLR10 gene cluster [95, 206].
Collectively, these studies suggest that archaic admixture has
been an important source of adaptive variation but also that
modern humans have inherited archaic variation that today
influences complex disease risk [158, 200].
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of adaptive mutations has increased in populations. Until
a few years ago, ancient DNA data were available only for
single individuals or specimens, limiting the analysis to
questions of comparative genomics. We learned a great
deal about the degree of admixture between modern
humans and ancient hominins, such as Neanderthals and
Denisovans, a topic that has been reviewed elsewhere
[16, 17, 156–158]. These studies have also revealed the
existence of advantageous “archaic” variants in the ge-
nomes of modern humans [16, 158]. These variants,
which were acquired through admixture with archaic
humans, have improved adaptation and survival in
modern humans (Fig. 1c, Box 2).
However, much less is known about genetic diversity
levels in populations of modern humans from different
eras, such as the Paleolithic and Neolithic periods. Deep
sequencing is making it possible to sequence multiple
samples per species or population, opening up new pos-
sibilities for the analysis of ancient DNA data within a
population genetics framework (see [156] for a review).
For example, in one recent study, 230 human samples
from West Eurasia dating from between 8500 and
2300 years ago were sequenced [132]. The authors searched
for abrupt changes in allele frequencies over time across
the genome. They identified 12 loci containing variants
with frequencies that rapidly increased over time, consistent
with positive selection. The lactase persistence variant
yielded one of the strongest signals and appeared to have
reached appreciable frequencies in Europe only recently
(less than 4000 years ago), as previously suggested [131].
The other strong signals identified were either directly or
indirectly related to diet, corresponding to genes encoding
proteins involved in fatty acid metabolism, vitamin D levels,
and celiac disease, or corresponded to genes involved in
skin pigmentation [132]. Interestingly, the authors also de-
tected strong selection signals in immunity-related genes,
such as the TLR1–TLR6–TLR10 gene cluster, which is
essential for the induction of inflammatory responses
and is associated with susceptibility to infectious diseases
[159, 160]. Thus, ancient DNA studies can help us to
understand the mode of selection following changes in
human lifestyle, and the extent to which such selective
events increased the frequency of functional alleles as-
sociated with specific traits or disease conditions [131,
132, 161, 162].
Insight into rare and common diseases from
natural selection
Genes associated with Mendelian or complex diseases
would be expected to be subject to unequal selective
pressures. We can therefore use selection signatures
to predict the involvement of genes in human disease
[11, 12, 32, 37, 115, 163]. Mendelian disorders are typicallysevere, compromising survival and reproduction, and are
caused by highly penetrant, rare deleterious mutations.
Mendelian disease genes should therefore fit the muta-
tion–selection balance model, with an equilibrium be-
tween the rate of mutation and the rate of risk allele
removal by purifying selection [12]. The use of population
genetics models is less straightforward when it comes to
Quintana-Murci Genome Biology  (2016) 17:225 Page 8 of 14predicting the genes involved in complex disease risk.
Models of adaptive evolution based on positive or bal-
ancing selection apply to a few Mendelian traits or
disorders, most notably, but not exclusively, those re-
lated to malaria resistance (reviewed in [76, 98]). How-
ever, the complex patterns of inheritance observed for
common diseases, including incomplete penetrance,
late onset and gene-by-environment interactions, make it
more difficult to decipher the connection between disease
risk and fitness [12].
Purifying selection, rare variants, and severe disorders
According to population genetics theory, strongly deleteri-
ous mutations are rapidly removed from the population by
purifying selection, whereas mildly deleterious mutations
generally remain present, albeit at low frequencies, depend-
ing on population sizes and fitness effects. Genome-wide
studies are providing increasing amounts of support for
these predictions, as “essential” genes—identified as such
on the basis of association with Mendelian diseases or ex-
perimental evidence from model organisms—are enriched
in signs of purifying selection [32, 37, 115, 164]. Purifying
selection has also been shown to be widespread in regula-
tory variation, acting against variants with large effects on
transcription, conserved noncoding regions of the genome,
and genes that are central in regulatory and protein–pro-
tein interaction networks [8, 10, 165–171].
Mutations associated with Mendelian diseases or with
deleterious effects on the phenotype of the organism are
generally rare and display familial segregation, but such
mutations may also be restricted to specific populations
[11]. This restriction, in some cases, may be due to a se-
lective advantage provided by the disease risk allele (e.g.,
the sickle cell allele in populations exposed to malaria
[98]), but it mostly reflects a departure from the muta-
tion–selection balance. Small population sizes or specific
demographic events may randomly increase the fre-
quency of some disease risk alleles, because too little
time has elapsed for purifying selection to remove them
from the population, as observed in French Canadians,
Ashkenazi Jews, or Finns [11, 66, 67].
According to these principles of population genetics,
searches for genes or functional elements evolving under
strong purifying selection can be used to identify the
genes of major relevance for survival, mutations of
which are likely to impair function and lead to severe
clinical phenotypes. In this context, the immune re-
sponse and host defense functions appear to be the
prime targets of purifying selection [37, 95, 102]. For ex-
ample, a recent study based on whole-genome sequences
from the 1000 Genomes Project estimated the degree to
which purifying selection acted on ~1500 innate immun-
ity genes. The genes of this class, taken as a whole, were
found to have evolved under globally stronger purifyingselection than the rest of the protein-coding genome
[95]. This study also assessed the strength of selective
constraints in the different innate immunity modules,
organizing these constraints into a hierarchy of bio-
logical relevance, and providing information about the
degree to which the corresponding genes were essential
or redundant [95].
Population genetics has also facilitated the identifica-
tion of immune system genes and signaling pathways
that fulfill essential, non-redundant functions in host
defense, variants of which are associated with severe,
life-threatening infectious diseases (for examples, see
[94, 95, 101, 106], and for reviews [29, 103, 172, 173]).
This is well illustrated by the cases of STAT1 and
TRAF3; they belong to the 1 % of genes presenting the
strongest signals of purifying selection at the genome-
wide level [95], and mutations in these genes have been
associated with severe viral and bacterial diseases, Men-
delian susceptibility to mycobacterial disease, and herpes
simplex virus 1 encephalitis [174, 175]. Using the para-
digm of immunity and infectious disease risk, these studies
highlight the value of population genetics as a comple-
ment to clinical and epidemiological genetic studies, for
determining the biological relevance of human genes in
natura and in predicting their involvement in human
disease [29, 103, 173, 176].
Genetic adaptation, common variants, and complex
disease
The relationship between selection and complex disease
risk is less clear than for Mendelian disorders, but pat-
terns are beginning to emerge. Genes associated with
complex disease display signs of less pervasive purifying
selection than Mendelian disease genes [32, 173], and
are generally enriched in signals of positive selection
[23, 28, 32, 37, 110, 122, 169]. There is also increasing
evidence to suggest that genetic adaptations can alter
complex disease susceptibility, and the population dis-
tribution of common susceptibility alleles is unlikely to
result from neutral processes alone [12, 91, 177–179].
For example, the difference in susceptibility to hyper-
tension and metabolic disorders between populations is
thought to result from past adaptation to different en-
vironmental pressures [91, 179, 180]. Another study
characterized the structure of complex genetic risk for
102 diseases in the context of human migration [178].
Differences between populations in the genetic risk of
diseases such as type 2 diabetes, biliary liver cirrhosis,
inflammatory bowel disease, systemic lupus erythema-
tosus, and vitiligo could not be explained by simple
genetic drift, providing evidence of a role for past genetic
adaptation [178]. Likewise, Grossman and coworkers
found overlaps between their candidate positively selected
regions and genes associated with traits or diseases in
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ated with infectious and autoimmune disease risks, includ-
ing tuberculosis and leprosy.
Like purifying selection, positive selection is prevalent
among genes related to immunity and host defense
[24, 37, 95, 109, 112, 115, 181]. Notable examples of
immunity-related genes evolving in an adaptive man-
ner, through different forms of positive or balancing
selection, and reported to be associated with complex
traits or diseases include:TLR1 and TLR5, which have
selection signals that seem to be related to decreases
in NF-kB signaling in Europe and Africa, respectively
[28, 94, 95]; many genes involved in malaria resistance
in Africa and Southeast Asia [98, 100]; type-III inter-
feron genes in Europeans and Asians, related to higher
levels of spontaneous viral clearance [101, 182];
LARGE and IL21, which have been implicated in Lassa
fever infectivity and immunity in West Africans [181];
and components of the NF-kB signaling pathway and
inflammasome activation related to cholera resistance
in a population from the Ganges river delta [97]. These
cases of selection related to infectious disease and many
others (see [29–31, 96, 103] for reviews and references
therein) indicate that the pressures imposed by infectious
disease agents have been paramount among the different
threats faced by humans [183]. They also highlight the
value of population genetics approaches in elucidating the
variants and mechanisms underlying complex disease risk.
Changes in selective pressures and advantageous/
deleterious variants
Most of the rare and common variants associated with
susceptibility to disease in modern populations have
emerged through neutral selection processes [184].
However, there is increasing evidence to suggest that,
following changes in environmental variables or human
lifestyle, alleles that were previously adaptive can be-
come “maladaptive” and associated with disease risk
[12, 13, 29, 30, 105]. For example, according to the
popular “thrifty genotype” hypothesis based on epidemio-
logical data, the high prevalence of type 2 diabetes and
obesity in modern societies results from the selection of
alleles associated with efficient fat and carbohydrate stor-
age during periods of famine in the past. Increases in food
abundance and a sedentary lifestyle have rendered these
alleles detrimental [185]. The strongest evidence that past
selection can lead to present-day maladaptation and
disease susceptibility is provided by infectious and in-
flammatory disorders [12, 29–31, 77, 105]. According
to the hygiene hypothesis, decreases in the diversity of
the microbes we are exposed to, following improve-
ments in hygiene and the introduction of antibiotics
and vaccines, have led to an imbalance in the immune
response, with alleles that helped us to fight infectionin the past now being associated with a higher risk of
inflammation or autoimmunity [105].
Population genetics studies have provided strong
support for the hygiene hypothesis, by showing that
genetic variants associated with susceptibility to certain
autoimmune, inflammatory, or allergic diseases, such as
inflammatory bowel disease, celiac disease, type 1 diabetes,
multiple sclerosis, and psoriasis, also display strong posi-
tive selection signals [29, 30, 106, 186–188]. For example,
genes conferring susceptibility to inflammatory diseases
have been shown to be enriched in positive selection sig-
nals, with the selected loci forming a highly intercon-
nected protein–protein interaction network, suggesting
that a shared molecular function was adaptive in the past
but now affects susceptibility to various inflammatory
diseases [187]. Greater protection against pathogens is
thought to be the most likely driver of past selection,
but it has been suggested that other traits, such as anti-
inflammatory conditions in utero, skin color, and hypoxic
responses, might account for the past selective advantage
of variants, contributing to the higher frequencies of
chronic disease risk alleles in current populations [30].
Additional molecular, clinical, and epidemiological studies
are required to support this hypothesis, but these observa-
tions highlight, more generally, the evolutionary trade-offs
between past selection and current disease risk in the con-
text of changes in environmental pressures and human
lifestyle.
Conclusions and future directions
Population genetics offers an alternative approach,
complementary to clinical and epidemiological genetic
studies, for the identification of disease risk alleles/
genes, the characterization of their properties, and the
understanding of the relative contributions of human
genetic variation to rare, severe disorders and complex
disease phenotypes. Recent studies have shown that
both ancient and recent demographic changes have
modified the burden of rare, deleterious variants segre-
gating in the population, whereas the population fre-
quencies of other variants have increased because they
conferred advantages in terms of better survival and
reproduction.
These studies have made a major contribution, but
further theoretical and empirical work is needed. Rare-
variant studies should consider different fitness and
dominance effects, epistatic interactions, and detailed
demographic modeling to evaluate the potential impact
of local changes in population size and admixture on the
efficiency of purifying selection. Furthermore, rare-variant
association studies involving complex traits or diseases
should seek to account for the evolutionary forces that
affect genetic architecture, such as selection and popula-
tion demography, and integrate elaborated models of
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allele frequency and effect size and the distribution of phe-
notypes, as recently reported [189]. Independently of the
complex interactions between demography and selection,
additional sequence-based studies are required to catalog
rare variants in different worldwide populations (including
isolated populations), focusing not only on point muta-
tions but also on indels, inversions, or copy-number vari-
ation, and evaluate their contribution to disease risk.
Studies of genetic adaptation, particularly those aiming
to make connections with disease in populations historic-
ally exposed to different environmental variables, should
generate whole-genome data for different worldwide pop-
ulations with greatly contrasting demographic histories,
lifestyles, and subsistence strategies. There is also a need
to develop and improve statistical approaches to facilitate
the detection of positive selection following alternative
modes of genetic adaptation, such as selection on standing
variation, polygenic adaptation, and adaptive introgression.
These selection studies, if combined with data for molecu-
lar phenotypes (e.g., gene expression, protein and metabol-
ite levels, epigenetic marks) and organismal phenotypes
(in health and disease), should provide great insight into
adaptive phenotypes of major relevance in human evo-
lution and the genetic architecture of rare and common
human diseases.
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